Peculiarities of bioaccumulation and toxic effects produced by copper oxide (ii) nanoparti-cles on the respiratory organs under inhalation exposure as opposed to their micro-sized chemical analogue: assessment for prevention purposes

View or download the full article: 
PDF icon health-risk-analysis-2023-4-12.pdf
UDC: 
613.632.2; 546.562; 615.916
DOI: 
10.21668/health.risk/2023.4.12.eng
Authors: 

M.S. Stepankov

Organization: 

Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, 82 Monastyrskaya St., Perm, 614045, Russian Federation

Abstract: 

At present, it is quite relevant to get better insight into parameters and peculiarities of deleterious effects produced by copper oxide nanoparticles (CuO NPs) on the respiratory organs under inhalation exposure. This will help develop more effective prevention measures.

The aim of this study was to assess peculiarities of bioaccumulation and toxic effects produced by CuO NPs on the respiratory organs as opposed to their micro-sized analogue in experimental modeling of inhalation exposure for prevention purposes.

We established physical properties of the tested materials. Experimental studies were accomplished on Wistar rats. The experimental animals underwent a single 4-hour inhalation exposure to a concentration of ~4 mg/m3; a subchronic inhalation exposure to a concentration of 1.2–1.4 mg/m3; a single intratracheal exposure to a dose of 0.005 grams per one rat. We examined peculiarities of NPs bioaccumulation, their influence on the cellular population of the bronchoalveolar lavage fluid (BALF), development of pathomorphological disorders in tissues, and the lung mass in comparison with the micro-sized analogue.

CuO NPs, as opposed to their micro-sized analogue, are smaller in size, have smaller hydrodynamic diameters, greater specific surface area and greater total pore volume; these properties determine their greater permeability.
Bioaccumulation in the lungs, which was identified for NPs and MPs, is comparable under a single inhalation exposure. Under chronic exposure, NPs tend to bioaccumulate more intensively. A single intratracheal exposure induces more apparent changes in the BALF cellular population. Exposure to NPs causes emphysema, edema, and erythrocyte exudation in the lungs whereas these effects are not identified under exposure to MPs.

Therefore, CuO NPs tend to accumulate more intensively and have more deleterious toxic effects on the respiratory organs (the lungs) than their micro-sized chemical analogue under a single intratracheal exposure (0.005 grams per one rat) and subchronic inhalation exposure (1.2 mg/m3). The study results should be considered when developing activities aimed at preventing negative health outcomes in the respiratory organs under inhalation exposure to the analyzed nanomaterial.

Keywords: 
copper (II) oxide, nanoparticles, microparticles, inhalation exposure, bioaccumulation, toxic effect, cellular phagocytic activity, Wistar rats
Stepankov M.S. Peculiarities of bioaccumulation and toxic effects produced by copper oxide (II) nanoparticles on the respiratory organs under inhalation exposure as opposed to their micro-sized chemical analogue: assessment for prevention purposes. Health Risk Analysis, 2023, no. 4, pp. 124–133. DOI: 10.21668/health.risk/2023.4.12.eng
References: 
  1. Mobasser S., Firoozi A.A. Review of nanotechnology applications in science and engineering. J. Civil Eng. Urban., 2017, vol. 6, no. 4, pp. 84–93.
  2. Khan I., Saeed K., Khan I. Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry, 2019, vol. 12, no. 7, pp. 908–931. DOI: 10.1016/j.arabjc.2017.05.011
  3. Zaitseva N.V., Zemlyanova M.A. Identification of health effects caused by environmental chemical exposure. In: G.G. Onishchenko ed. Perm, Knizhnyi format, 2011, 532 p. (in Russian).
  4. Zolina L.I., Gracheva K.О. Physicochemical and biochemical properties of metallic nanoparticles and their applications. Industrial Processes and Technologies, 2022, vol. 2, no. 1, pp. 29–38. DOI: 10.37816/2713-0789-2022-2-1-29-38 (in Russian).
  5. Kovaleva N.Yu., Raevskaya Е.G., Roshchin А.V. Aspects of nanomaterial safety: nanosafety, nanotoxicology, nanoinformatics. Khimicheskaya bezopasnost', 2017, vol. 1, no. 2, pp. 44–87. DOI: 10.25514/CHS.2017.2.10982 (in Russian).
  6. Global nano copper oxide market report 2022 to 2027: industry trends, share, size, growth, opportunities and forecasts. Research and Markets. Available at: https://www.globenewswire.com/
    news-release/2022/12/23/2579082/0/en/Global-Nano-Copper-Oxide-Market-Report-2022-to-2027-In¬dus¬try-Trends-Share-Size-Growth-Opportunities-and-Forecasts.html (August 30, 2023).
  7. Naz S., Gul A., Zia M., Javed R. Synthesis, biomedical applications, and toxicity of CuO nanoparticles. Applied Microbiology and Biotechnology, 2023, vol. 107, pp. 1039–1061. DOI: 10.1007/s00253-023-12364-z
  8. Vats M., Bhardwaj S., Chhabra A. Green synthesis of copper oxide nanoparticles using Cucumis sativus (Cucumber) extracts and their bio-physical and biochemical characterization for cosmetic and dermatologic applications. Endocrine, Metabolic & Immune Disorders Drug Targets, 2021, vol. 21, no. 4, pp. 726–733. DOI: 10.2174/1871530320666200705212107
  9. Margenot A.J., Rippner D.A., Dumlao M.R., Nezami S., Green P.G., Parikh S.J., McElrone A.J. Copper oxide nanoparticle effects on root growth and hydraulic conductivity of two vegetable crops. Plant Soil, 2018, vol. 431, pp. 333–345. DOI: 10.1007/s11104-018-3741-3
  10. Rahman A., Pittarate S., Perumal V., Rajula J., Thungrabeab M., Mekchay S., Krutmuang P. Larvicidal and antifeedant effects of copper nano-pesticides against Spodoptera frugiperda
    (J.E. Smith) and its immunological response. Insects, 2022, vol. 13, no. 11, pp. 1030. DOI: 10.3390/insects13111030
  11. Chen W., Zhu B., Sun Y., Guo P., Liu J. Nano-sized copper oxide enhancing the combustion of aluminum/kerosene-based nanofluid fuel droplets. Combustion and Flame, 2022, vol. 240, pp. 112028. DOI: 10.1016/j.combustflame.2022.112028
  12. Rita A., Sivakumar A., Martin Britto Dhas S.A. Influence of shock waves on structural and morphological properties of copper oxide NPs for aerospace applications. J. Nanostruct. Chem., 2019, vol. 9, pp. 225–230. DOI: 10.1007/s40097-019-00313-0
  13. Sarkar A., Das J., Manna P., Sil P.C. Nano-copper induces oxidative stress and apoptosis in kidney via both extrinsic and intrinsic pathways. Toxicology, 2011, vol. 290, no. 2–3, pp. 208–217. DOI: 10.1016/j.tox.2011.09.086
  14. Edelmann M.J., Shack L.A., Naske C.D., Walters K.B., Nanduri B. SILAC-based quantitative proteomic analysis of human lung cell response to copper oxide nanoparticles. PLoS One, 2014, vol. 9, no. 12, pp. e114390. DOI: 10.1371/journal.pone.0114390
  15. Sajjad H., Sajjad A., Haya R.T., Khan M.M., Zia M. Copper oxide nanoparticles: In vitro and in vivo toxicity, mechanisms of action and factors influencing their toxicology. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2023, vol. 271, pp. 109682. DOI: 10.1016/j.cbpc.2023.109682
  16. Peng C., Shen C., Zheng S., Yang W., Hu H., Liu J., Shi J. Transformation of CuO nanoparticles in the aquatic environment: influence of pH, electrolytes and natural organic matter. Nanomaterials (Basel), 2017, vol. 7, no. 10, pp. 326. DOI: 10.3390/nano7100326
  17. Areecheewakul S., Adamcakova-Dodd A., Haque E., Jing X., Meyerholz D.K., O’Shaugh¬nessy P.T., Thorne P.S., Salem A.K. Time course of pulmonary inflammation and trace element biodistribution during and after sub-acute inhalation exposure to copper oxide nanoparticles in a murine model. Part. Fibre Toxicol., 2022, vol. 19, no. 1, pp. 40. DOI: 10.1186/s12989-022-00480-z
  18. Oberdoster G., Oberdoster E., Oberdoster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect., 2005, vol. 113, no. 7, pp. 823–839. DOI: 10.1289/ehp.7339
  19. Nazarenko G.I., Kishkun A.A. Klinicheskaya otsenka rezul'tatov laboratornykh issledovanii [Clinical estimation of laboratory results]. Moscow, Meditsina, 2006, 544 p. (in Russian).
  20. Stanzel F. Bronchoalveolar Lavage. In book: Principles and Practice of Interventional Pul-monology. In: A. Ernst, F.J.F. Herth eds. New York, Springer, 2013, pp. 165–176. DOI: 10.1007/978-1-4614-4292-9_16
  21. Anreddy R.N.R. Copper oxide nanoparticles induces oxidative stress and liver toxicity in rats following oral exposure. Toxicol. Rep., 2018, no. 5, pp. 903–904. DOI: 10.1016/j.toxrep.2018.08.022
  22. Keshavarzi M., Khodaei F., Siavashpour A., Saeedi A., Mohammadi-Bardbori A. Hormesis Effects of Nano- and Micro-sized Copper Oxide. Iran. J. Pharm. Res., 2019, vol. 18, no. 4, pp. 2042–2054. DOI: 10.22037/ijpr.2019.13971.12030
  23. Bulua A.C., Simon A., Maddipati R., Pelletier M., Park H., Kim K.-Y., Sack M.N., Kastner D.L., Siegel R.M. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J. Exp. Med., 2011, vol. 208, no. 3, pp. 519–533. DOI: 10.1084/jem.20102049
  24. Khatami M. Developmental phases of inflammation-induced massive lymphoid hyperplasia and extensive changes in epithelium is an experimental model of allergy: implications for a direct link between inflammation and carcinogenesis. Am. J. Ther., 2005, vol. 12, no. 2, pp. 117–126. DOI: 10.1097/01.mjt.0000143699.91156.21
  25. Samsonova М.V., Chernyaev А.L. Primary lymphoid lung lesions. Prakticheskaya pul'mono¬logiya, 2016, no. 3, pp. 71–75 (in Russian).
  26. Gosens I., Cassee F.R., Zanella M., Manodori L., Brunelli A., Costa A.L., Bokkers B.G.H., de Jong W.H. [et al.]. Organ burden and pulmonary toxicity of nano-sized copper (II) oxide particles after short-term inhalation exposure. Nanotoxicology, 2016, vol. 10, no. 8, pp. 1084–1095. DOI: 10.3109/17435390.2016.1172678
  27. Goldklang M., Stockley R. Pathophysiology of Emphysema and Implications. Chronic Obstr. Pulm. Dis., 2016, vol. 3, no. 1, pp. 454–458. DOI: 10.15326/jcopdf.3.1.2015.0175
  28. Jasper A.E., Mclver W.J., Sapey E., Walton G.M. Understanding the role of neutrophils in chronic inflammatory airway disease. F1000 Res., 2019, vol. 8, pp. 557. DOI: 10.12688/f1000research.18411.1
  29. Kaptein F.H.J., Kroft L.J.M., Hammerschlag G., Ninamber M.K., Bauer M.P., Huisman M.V., Klok F.A. Pulmonary infarction in acute pulmonary embolism. Thromb. Res., 2021, vol. 202, pp. 162–169. DOI: 10.1016/j.thromres.2021.03.022
  30. Willson C., Watanabe M., Tsuji-Hosokawa A., Makino A. Pulmonary vascular dysfunction in metabolic syndrome. J. Physiol., 2019, vol. 597, no. 4, pp. 1121–1141. DOI: 10.1113/JP275856
  31. Stepankov M.S., Zemlyanova M.A., Zaitseva N.V., Ignatova A.M., Nikolaeva A.E. Features of Bioaccumulation and Toxic Effects of Copper (II) Oxide Nanoparticles Under Repeated Oral Exposure in Rats. Pharm. Nanotechnol., 2021, vol. 9, no. 4, pp. 288–297. DOI: 10.2174/22117385096662107281639011
Received: 
20.08.2023
Approved: 
23.10.2023
Accepted for publication: 
20.12.2023

You are here

Home